Due to its correlation with CSC markers and the detected overexpression of FAK in HCC tissue, which is also associated with increased tumorigenicity, lower overall survival, and increased recurrence, the authors regard FAK as a prognostic/diagnostic marker in HCC [161]. This evidence concerns the gene PTK2 and hepatocellular carcinoma.